These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 3734433)
1. Purified Vero cell rabies vaccine and human diploid cell strain vaccine: comparison of neutralizing antibody responses to post-exposure regimens. Suntharasamai P; Chanthavanich P; Warrell MJ; Looareesuwan S; Karbwang J; Supanaranond W; Phillips RE; Jansawan W; Xueref C; Pouradier-Duteil X J Hyg (Lond); 1986 Jun; 96(3):483-9. PubMed ID: 3734433 [TBL] [Abstract][Full Text] [Related]
2. Immunogenicity and Safety of a Purified Vero Rabies Vaccine-Serum Free, Compared With 2 Licensed Vaccines, in a Simulated Rabies Post-Exposure Regimen in Healthy Adults in France: A Randomized, Controlled, Phase 3 Trial. Pineda-Peña AC; Jiang Q; Petit C; Korejwo-Peyramond J; Donazzolo Y; Latreille M; Homery MC; Babin V; Benamor S; Pichon S; Guinet-Morlot F; Minutello AM Clin Infect Dis; 2024 Jun; 78(6):1748-1756. PubMed ID: 38478634 [TBL] [Abstract][Full Text] [Related]
3. Early antibody responses to rabies post-exposure vaccine regimens. Suntharasamai P; Warrell MJ; Warrell DA; Chanthavanich P; Looareesuwan S; Supapochana A; Phanuphak P; Jittapalapongsa S; Yager PA; Baer GM Am J Trop Med Hyg; 1987 Jan; 36(1):160-5. PubMed ID: 3812881 [TBL] [Abstract][Full Text] [Related]
4. Immunogenicity and safety in adults of a new chromatographically purified Vero-cell rabies vaccine (CPRV): a randomized, double-blind trial with purified Vero-cell rabies vaccine (PVRV). Lang J; Cetre JC; Picot N; Lanta M; Briantais P; Vital S; Le Mener V; Lutsch C; Rotivel Y Biologicals; 1998 Dec; 26(4):299-308. PubMed ID: 10403033 [TBL] [Abstract][Full Text] [Related]
5. An economical regimen of human diploid cell strain anti-rabies vaccine for post-exposure prophylaxis. Warrell MJ; Warrell DA; Suntharasamai P; Viravan C; Sinhaseni A; Udomsakdi D; Phanfung R; Xueref C; Vincent-Falquet JC; Nicholson KG; Bunnag D; Harinasuta T Lancet; 1983 Aug; 2(8345):301-4. PubMed ID: 6135830 [TBL] [Abstract][Full Text] [Related]
6. Rabies neutralizing antibody after 2 intradermal doses on days 0 and 21 for pre-exposure prophylaxis. Wongsaroj P; Udomchaisakul P; Tepsumethanon S; Khawplod P; Tantawichien T Vaccine; 2013 Mar; 31(13):1748-51. PubMed ID: 23370149 [TBL] [Abstract][Full Text] [Related]
7. A comparative study on the safety and immunogenicity of Purified duck embryo vaccine [corrected] (PDEV, Vaxirab) with purified chick embryo cell vaccine (PCEC, Rabipur) and purifed vero cell rabies vaccine (PVRV, Verorab). Ashwathnarayana DH; Madhusudana SN; Sampath G; Sathpathy DM; Mankeshwar R; Ravish HH; Ullas PT; Behra TR; Sudarshan MK; Gangaboraiah ; Shamanna M Vaccine; 2009 Dec; 28(1):148-51. PubMed ID: 19818720 [TBL] [Abstract][Full Text] [Related]
8. Simulated post-exposure rabies vaccination with purified chick embryo cell vaccine using a modified Thai Red Cross regimen. Madhusudana SN; Sanjay TV; Mahendra BJ; Suja MS Int J Infect Dis; 2004 May; 8(3):175-9. PubMed ID: 15109593 [TBL] [Abstract][Full Text] [Related]
9. Protecting Indian schoolchildren against rabies: pre-exposure vaccination with purified chick embryo cell vaccine (PCECV) or purified verocell rabies vaccine (PVRV). Shanbag P; Shah N; Kulkarni M; Juvekar M; Madhusudana SN; Vakil HB; Malerczyk C Hum Vaccin; 2008; 4(5):365-9. PubMed ID: 18398307 [TBL] [Abstract][Full Text] [Related]
10. Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine. Briggs DJ; Banzhoff A; Nicolay U; Sirikwin S; Dumavibhat B; Tongswas S; Wasi C Bull World Health Organ; 2000; 78(5):693-8. PubMed ID: 10859864 [TBL] [Abstract][Full Text] [Related]
11. A randomized open-labeled study to demonstrate the non-inferiority of purified chick-embryo cell rabies vaccine administered in the Zagreb regimen (2-1-1) compared with the Essen regimen in Chinese adults. Ma J; Wang H; Li J; Chang L; Xie Y; Liu Z; Zhao Y; Malerczyk C Hum Vaccin Immunother; 2014; 10(10):2805-12. PubMed ID: 25483635 [TBL] [Abstract][Full Text] [Related]
12. Rabies post-exposure prophylaxis vaccination with purified chick embryo cell vaccine (PCECV) and purified Vero cell rabies vaccine (PVRV) in a four-site intradermal schedule (4-0-2-0-1-1): an immunogenic, cost-effective and practical regimen. Ambrozaitis A; Laiskonis A; Balciuniene L; Banzhoff A; Malerczyk C Vaccine; 2006 May; 24(19):4116-21. PubMed ID: 16545510 [TBL] [Abstract][Full Text] [Related]
13. Shortening intradermal rabies post-exposure prophylaxis regimens to 1 week: Results from a phase III clinical trial in children, adolescents and adults. Kerdpanich P; Chanthavanich P; De Los Reyes MR; Lim J; Yu D; Ama MC; Mojares Z; Casula D; Arora AK; Pellegrini M PLoS Negl Trop Dis; 2018 Jun; 12(6):e0006340. PubMed ID: 29874228 [TBL] [Abstract][Full Text] [Related]
14. New purified Vero-cell vaccine prevents rabies in patients bitten by rabid animals. Suntharasamai P; Warrell MJ; Warrell DA; Viravan C; Looareesuwan S; Supanaranond W; Chanthavanich P; Supapochana A; Tepsumethanon W; Pouradier-Duteil X Lancet; 1986 Jul; 2(8499):129-31. PubMed ID: 2873399 [TBL] [Abstract][Full Text] [Related]
15. Safety and immunogenicity of a new purified vero cell rabies vaccine (PVRV) administered by intramuscular and intradermal routes in healthy volunteers. Kulkarni PS; Sapru A; D'costa PM; Pandit A; Madhusudana SN; Yajaman AB; Mangrule S; Gunale B; Bavdekar AR Vaccine; 2013 May; 31(24):2719-22. PubMed ID: 23583817 [TBL] [Abstract][Full Text] [Related]
16. Comparison of saftey and immunogenicity of purified chick embryo cell rabies vaccine (PCECV) and purified vero cell rabies vaccine (PVRV) using the Thai Red Cross intradermal regimen at a dose of 0.1 ML. Madhusudana SN; Sanjay TV; Mahendra BJ; Sudarshan MK; Narayana DH; Giri A; Muhamuda K; Ravi V; Vakil HB; Malerczyk C Hum Vaccin; 2006; 2(5):200-4. PubMed ID: 17035734 [TBL] [Abstract][Full Text] [Related]
17. Immunogenicity and safety of purified vero cell rabies vaccine (PVRV) produced by Liaoning Cheng Da Co. under Zagreb 2-1-1 or 5-dose Essen regimen in Chinese adults aged 50 and above. Wang J; Luo F; Feng Z; Li L; Bai Y; Ai X; Ma J; Zhang Z; Shi N Hum Vaccin Immunother; 2017 Jan; 13(1):144-150. PubMed ID: 28045585 [TBL] [Abstract][Full Text] [Related]
18. Safety and immunogenicity of chromatographically purified Vero cell rabies vaccine for intradermal pre- and post-exposure rabies prophylaxis. Tantawichien T; Sibunruang S; Tantawichien T; Angsanakul J; Benjavongkulchai M; Limsuwan K; Udomchaisakul P; Khomvilai S; Sitprija V Expert Rev Vaccines; 2014 Dec; 13(12):1593-601. PubMed ID: 25315021 [TBL] [Abstract][Full Text] [Related]
19. Studies on clinical trials and immune effect of a new purified rabies vaccine prepared from Vero cells. Dong G; Zheng H; Liu Z Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Mar; 14(1):19-23. PubMed ID: 11503018 [TBL] [Abstract][Full Text] [Related]
20. Humoral and cell-mediated immune responses to various economical regimens of purified Vero cell rabies vaccine. Phanuphak P; Khawplod P; Sirivichayakul S; Siriprasomsub W; Ubol S; Thaweepathomwat M Asian Pac J Allergy Immunol; 1987 Jun; 5(1):33-7. PubMed ID: 3620048 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]